Consequences of oral antithrombotic use in patients with chronic kidney disease.
Laville SM, Lambert O, Hamroun A, Metzger M, Jacquelinet C, Laville M, Frimat L, Fouque D, Combe C, Ayav C, Pecoits-Filho R, Stengel B, Massy ZA, Liabeuf S; CKD-REIN Study Collaborators.
Laville SM, et al. Among authors: ayav c.
Clin Transl Sci. 2021 Nov;14(6):2242-2253. doi: 10.1111/cts.13084. Epub 2021 Jun 24.
Clin Transl Sci. 2021.
PMID: 34080321
Free PMC article.